296 related articles for article (PubMed ID: 22696812)
1. Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta.
Singh M; Kindelberger D; Nagymanyoki Z; Ng SW; Quick CM; Yamamoto H; Fichorova R; Fulop V; Berkowitz RS
J Reprod Med; 2012; 57(5-6):197-203. PubMed ID: 22696812
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
3. c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Szigetvari I; Cseh I; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):101-10. PubMed ID: 9513871
[TBL] [Abstract][Full Text] [Related]
4. Levels of placenta growth factor in gestational trophoblastic diseases.
Okamoto T; Niu R; Mizutani S; Yamada S
Am J Obstet Gynecol; 2003 Jan; 188(1):135-40. PubMed ID: 12548207
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
6. [The c-erbB-related oncoproteins in normal placenta and in gestational trophoblastic diseases (in vitro study)].
Fülöp V; Végh G; Doszpod J
Orv Hetil; 2001 Jun; 142(22):1147-54. PubMed ID: 11424588
[TBL] [Abstract][Full Text] [Related]
7. p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma.
Fulop V; Mok SC; Genest DR; Gati I; Doszpod J; Berkowitz RS
J Reprod Med; 1998 Feb; 43(2):119-27. PubMed ID: 9513873
[TBL] [Abstract][Full Text] [Related]
8. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction.
Khaliq A; Dunk C; Jiang J; Shams M; Li XF; Acevedo C; Weich H; Whittle M; Ahmed A
Lab Invest; 1999 Feb; 79(2):151-70. PubMed ID: 10068204
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta.
Tseng JJ; Chou MM; Hsieh YT; Wen MC; Ho ES; Hsu SL
Placenta; 2006 Jan; 27(1):70-8. PubMed ID: 16310040
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women.
Pietro L; Daher S; Rudge MV; Calderon IM; Damasceno DC; Sinzato YK; Bandeira C; Bevilacqua E
Placenta; 2010 Sep; 31(9):770-80. PubMed ID: 20674013
[TBL] [Abstract][Full Text] [Related]
12. Human choriocarcinomas: placental growth factor-dependent preclinical tumor models.
Bagley RG; Ren Y; Kurtzberg L; Weber W; Bangari D; Brondyk W; Teicher BA
Int J Oncol; 2012 Feb; 40(2):479-86. PubMed ID: 22075622
[TBL] [Abstract][Full Text] [Related]
13. Localization of vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 and VEGFR-2 in bovine placentomes from implantation until term.
Pfarrer CD; Ruziwa SD; Winther H; Callesen H; Leiser R; Schams D; Dantzer V
Placenta; 2006 Aug; 27(8):889-98. PubMed ID: 16263165
[TBL] [Abstract][Full Text] [Related]
14. [Expression of VEGFA, VEGFC, angiopoietin-1, angiopoietin-2 and their receptors on yolk sac blood island, aorta-gonad-mesonephros (AGM) region of human embryo].
Jiang JY; Li AD; Mei Y; Zhou HY; Yang HJ; Yang SX; Hong HR; Song HR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):249-54. PubMed ID: 15228644
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
[TBL] [Abstract][Full Text] [Related]
16. Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.
Onofri C; Theodoropoulou M; Losa M; Uhl E; Lange M; Arzt E; Stalla GK; Renner U
J Endocrinol; 2006 Oct; 191(1):249-61. PubMed ID: 17065408
[TBL] [Abstract][Full Text] [Related]
17. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1alpha), and transforming growth factors beta1 (TGFbeta1) and beta3 (TGFbeta3) in gestational trophoblastic disease.
Bolat F; Haberal N; Tunali N; Aslan E; Bal N; Tuncer I
Pathol Res Pract; 2010 Jan; 206(1):19-23. PubMed ID: 19836147
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factors and receptors are up-regulated during development of apical periodontitis.
Bletsa A; Virtej A; Berggreen E
J Endod; 2012 May; 38(5):628-35. PubMed ID: 22515891
[TBL] [Abstract][Full Text] [Related]
20. Expression pattern of the adhesion molecule CEACAM1 (C-CAM, CD66a, BGP) in gestational trophoblastic lesions.
Bamberger AM; Sudahl S; Wagener C; Löning T
Int J Gynecol Pathol; 2001 Apr; 20(2):160-5. PubMed ID: 11293162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
